Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Carlisle Companies Inc (CSL)

Carlisle Companies Inc (CSL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Chart of the Day: Carlisle Keeps Building

The Chart of the Day belongs to the building products and equipment company Carlisle Companies (CSL) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest...

CSL : 388.62 (+0.03%)
Health Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B

/CNW/ -- Global biotechnology leader CSL (ASX: CSL) today announced that Health Canada has authorized HEMGENIX® (etranacogene dezaparvovec), the first and only...

CSL.AX : 287.920 (+0.55%)
CSL : 388.62 (+0.03%)
New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines

Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among...

CSL : 388.62 (+0.03%)
CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems

Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following...

CSL : 388.62 (+0.03%)
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...

CSL : 388.62 (+0.03%)
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

CSL : 388.62 (+0.03%)
CSLLY : 93.8800 (+1.70%)
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season

CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the...

CSL : 388.62 (+0.03%)
4 Industrial Stocks That Are Screaming Buys in June

These vital manufacturers could produce stellar returns.

CAT : 364.65 (unch)
MMM : 104.38 (-0.20%)
CSL : 388.62 (+0.03%)
DOV : 177.22 (+1.40%)
Carlisle (CSL) Q1 Earnings Miss Estimates, Sales Decline Y/Y

Carlisle's (CSL) first-quarter 2023 earnings decline 39.7% on a year-over-year basis due to lower sales.

PH : 558.05 (+1.62%)
IR : 95.26 (unch)
CSL : 388.62 (+0.03%)
ALLE : 134.24 (+0.67%)
Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on June 1, 2023, to shareholders of record at the close of business on May 17, 2023.

CSL : 388.62 (+0.03%)

Barchart Exclusives

2 Growth Stocks With 20% to 40% Upside in 2024
Both of these companies’ innovative products present excellent long-term opportunities for investors seeking growth in the stock market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar